Sartorius Stedim Biotech (id:10585 DIM)
180.40 EUR
Opening hours: 09:00 - 17:30 (Central European Standard Time: 11/27/2024 2:06:51 PM)
Exchange open, closes in 3 hours 23 minutes
About Sartorius Stedim Biotech
Market Capitalization 16.40B
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
| Headquarters (address) |
Zone Industrielle Les Paluds Aubagne 13781 France |
| Phone | 33 4 42 84 56 00 |
| Website | https://www.sartorius.com |
| Employees | 10,082 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Ticker | DIM |
| Exchange | European Stock Exchange |
| Currency | EUR |
| 52 week range | 139.10 - 281.00 |
| Market Capitalization | 16.40B |
| Dividend yield forward | 1.55 % |
| Dividend yield forward France (ID:70, base:257) | 16.26 % |
| P/E trailing | 100.36 |
| P/E forward | 39.12 |
| Price/Sale | 6.00 |
| Price/Book | 4.24 |
| Beta | 0.666 |
| EPS | 1.68 |
| EPS France (ID:70, base:331) | -1.54 |
Dividend growth streak
Sartorius Stedim Biotech has raised their dividend 2.00 years in a row. This is below the 4.478450 year average in the 'Medical Instruments & Supplies' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Sartorius Stedim Biotech has raised their dividend 1.55 years in a row. This is below the 41466.163900 year average in the 'Medical Instruments & Supplies' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Sartorius Stedim Biotech has raised their dividend 12.18 years in a row. This is below the 24.033000 year average in the 'Medical Instruments & Supplies' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Sartorius Stedim Biotech has raised their dividend 25.64 years in a row. This is above the 12.576000 year average in the 'Medical Instruments & Supplies' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Sartorius Stedim Biotech has raised their dividend 22.89 years in a row. This is above the 10.158800 year average in the 'Medical Instruments & Supplies' industry
Payout Ratio
Payout Ratio: Sartorius Stedim Biotech has raised their dividend 41.07 years in a row. This is below the 147.849600 year average in the 'Medical Instruments & Supplies' industry
Dividend growth streak
Sartorius Stedim Biotech has raised their dividend 2.00 years in a row. This is below the 4.478450 year average in the 'Medical Instruments & Supplies' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Sartorius Stedim Biotech has raised their dividend 1.55 years in a row. This is below the 41466.163900 year average in the 'Medical Instruments & Supplies' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Sartorius Stedim Biotech has raised their dividend 12.18 years in a row. This is below the 24.033000 year average in the 'Medical Instruments & Supplies' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Sartorius Stedim Biotech has raised their dividend 25.64 years in a row. This is above the 12.576000 year average in the 'Medical Instruments & Supplies' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Sartorius Stedim Biotech has raised their dividend 22.89 years in a row. This is above the 10.158800 year average in the 'Medical Instruments & Supplies' industry
Payout Ratio
Payout Ratio: Sartorius Stedim Biotech has raised their dividend 41.07 years in a row. This is below the 147.849600 year average in the 'Medical Instruments & Supplies' industry